Clinical Trial Update: Papua New Guinean Duffy Negativity And Vivax Malar

View source ↗

Summary

Clinical trial status update indicates the study examining Duffy negativity and Plasmodium vivax malaria in Papua New Guinea has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Vivax Malaria

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Plasmodium Vivax Malaria | Status: TERMINATED